The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / O•••••• I•••

S•••••• acquires O•••••• I•••, adding lipids expertise and a strategic foothold in the US

Add-on acquisitionannouncedadd-onannounced Apr 26, 2022Fact
What happened
Platform
S••••••add-on basis: S•••••• acquires O•••••• I•••, adding lipids expertise and a strategic foothold in the US | S•••••• is held by K•••••••• C•••••• on its portfolio page; published on K•••••••• C••••••'s own news page
Control
Control
Share acquired
unknown
Industry
unknown
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
4 named
Buy side
  • A••• K••••, Partner at K•••••••• C••••••, comments: “We are delighted to support S•••••• in this exciting acquisition of O••••••.
  • S••••••Platformconfirmed
    S•••••• acquires O•••••• I•••, adding lipids expertise and a strategic foothold in the US | S•••••• is held by K•••••••• C•••••• on its portfolio page; published on K•••••••• C••••••'s own news page
  • S•••••• acquires O•••••• I•••, adding lipids expertise and a strategic foothold in the US | S•••••• is held by K•••••••• C•••••• on its portfolio page; published on K•••••••• C••••••'s own news page
Side not stated
  • S•••••• acquires O•••••• I•••, adding lipids expertise and a strategic foothold in the US
Evidence
S•••••• acquires O•••••• I•••, adding lipids expertise and a strategic foothold in the US